Intermittent Prophylaxis with Oral Truvada Protects Macaques from Rectal SHIV Infection
- 13 January 2010
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 2 (14), 14ra4
- https://doi.org/10.1126/scitranslmed.3000391
Abstract
Treating monkeys with single doses of an antiretroviral drug before and after exposure to SHIV provides protection against infection, a schedule that may prove practical in humans.Keywords
This publication has 35 references indexed in Scilit:
- Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infectionCochrane Database of Systematic Reviews, 2011
- Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in ThailandNew England Journal of Medicine, 2009
- A preemptive strike against HIVNature Medicine, 2009
- Biomedical interventions to prevent HIV infection: evidence, challenges, and way forwardThe Lancet, 2008
- Extended Antiretroviral Prophylaxis to Reduce Breast-Milk HIV-1 TransmissionNew England Journal of Medicine, 2008
- Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infectionProceedings of the National Academy of Sciences, 2008
- Prevention of Rectal SHIV Transmission in Macaques by Daily or Intermittent Prophylaxis with Emtricitabine and TenofovirPLoS Medicine, 2008
- Chemoprophylaxis with Tenofovir Disoproxil Fumarate Provided Partial Protection against Infection with Simian Human Immunodeficiency Virus in Macaques Given Multiple Virus ChallengesThe Journal of Infectious Diseases, 2006
- Evaluation of Oral Tenofovir Disoproxil Fumarate and Topical Tenofovir GS-7340 to Protect Infant Macaques Against Repeated Oral Challenges With Virulent Simian Immunodeficiency VirusJAIDS Journal of Acquired Immune Deficiency Syndromes, 2006
- A Case–Control Study of HIV Seroconversion in Health Care Workers after Percutaneous ExposureNew England Journal of Medicine, 1997